- Home
- BCML vs INBX Comparison
BCML vs INBX Comparison
Compare BCML & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCML
- INBX
- Stock Information
- Founded
- BCML 2004
- INBX 2010
- Country
- BCML United States
- INBX United States
- Employees
- BCML N/A
- INBX N/A
- Industry
- BCML Major Banks
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- BCML Finance
- INBX Health Care
- Exchange
- BCML Nasdaq
- INBX Nasdaq
- Market Cap
- BCML 261.8M
- INBX 237.5M
- IPO Year
- BCML N/A
- INBX 2020
- Fundamental
- Price
- BCML $24.18
- INBX $15.74
- Analyst Decision
- BCML
- INBX Hold
- Analyst Count
- BCML 0
- INBX 1
- Target Price
- BCML N/A
- INBX N/A
- AVG Volume (30 Days)
- BCML 17.6K
- INBX 104.9K
- Earning Date
- BCML 10-25-2024
- INBX 08-13-2024
- Dividend Yield
- BCML 1.66%
- INBX N/A
- EPS Growth
- BCML N/A
- INBX N/A
- EPS
- BCML 2.12
- INBX 118.83
- Revenue
- BCML $97,490,000.00
- INBX $1,687,000.00
- Revenue This Year
- BCML N/A
- INBX N/A
- Revenue Next Year
- BCML $3.40
- INBX N/A
- P/E Ratio
- BCML $11.35
- INBX $0.13
- Revenue Growth
- BCML N/A
- INBX 24.26
- 52 Week Low
- BCML $18.54
- INBX $10.80
- 52 Week High
- BCML $25.04
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- BCML 60.75
- INBX 53.98
- Support Level
- BCML $23.25
- INBX $15.31
- Resistance Level
- BCML $24.40
- INBX $16.35
- Average True Range (ATR)
- BCML 0.38
- INBX 0.58
- MACD
- BCML 0.03
- INBX -0.05
- Stochastic Oscillator
- BCML 82.95
- INBX 63.69
About BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.